معرفی
Jeremy Puthumana is a Clinical Assistant Professor in the Department of Internal Medicine at Yale School of Medicine. He holds an MD and MS from Yale University. His research focuses on kidney injury biomarkers, clinical trial methodologies, and FDA regulatory science. Notable work includes systematic reviews on urine biomarkers for acute kidney injury in cirrhosis and analyses of FDA approval processes for vaccines and gene therapies. He is affiliated with the ABIM Physician-Scientist Research Pathway and has contributed to studies on biomarkers in kidney transplantation and clinical trial diversity. His work bridges clinical practice with translational research, emphasizing evidence-based regulatory frameworks and patient outcomes in critical care settings.
Education:
- MD, Yale School of Medicine
- MS, Yale University
- BS, Yale University
Research Interests:
- Biomarker discovery for renal and hepatic diseases
- Optimizing clinical trial designs for accelerated therapies
- Regulatory science for FDA approvals
- Post-cardiac surgery outcomes and cardiovascular risks
Key Research Trends: His recent articles highlight trends in leveraging biomarkers for diagnostic precision, analyzing FDA regulatory pathways for novel therapies, and addressing demographic gaps in clinical trial participation. These studies emphasize interdisciplinary collaboration between nephrology, hepatology, and public health.
Grants & Advising: While no formal advisees are listed, his research collaborations involve prominent figures like Chirag Parikh and Pramod Mistry. He has contributed to funded projects on AKI biomarkers and vaccine approval analyses.
Labs/Teams: Affiliated with the ABIM Physician-Scientist Research Pathway and the Department of Internal Medicine’s clinical research initiatives.